RxDoctor Payments Data

Jean Eloy, MD

Anesthesiology · Newark, NJNPI 1538328851

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Acclarent, Inc at 50.0% of the total. Reporting peaked in 2022 at $115 and has fallen 87.1% since, to $15 in 2023.

$230in general payments, 2019–2025

Across 4 payments — averaging $57.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$115
  • Heron Therapeutics, Inc.$90
  • Eagle Pharmaceuticals, Inc.$15
  • Acacia Pharma Inc$11
$290,489in research payments, 2019–2025

Across 34 payments — averaging $8543.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$227K
  • Heron Therapeutics, Inc.$62K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K

What the payments were for

  • Food & beverage$230100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$230 in reported general payments places this provider in the 60th percentile of 1,430 anesthesiology providers in New Jersey.

See all anesthesiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$15,071
Medicare patients
49
Services billed
75

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Newark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →